Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07086794 · ClinicalTrials.gov registry record · Early Phase 1
Cocaine and Pentoxifylline (BED IN 47)
A Early Phase 1 study of Cocaine Use Disorder, sponsored by William Stoops.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07086794 is a Early Phase 1 study of Cocaine Use Disorder that is actively recruiting participants, run by William Stoops. The registered enrollment target is 30 participants, below the 103-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07086794, a Early Phase 1 study of Cocaine Use Disorder, is actively recruiting participants, sponsored by William Stoops.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a human laboratory study evaluating the influence of pentoxifylline treatment on the effects of cocaine. Supported by and included in the Helping to End Addiction Long-term® (HEAL) Initiative.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Pentoxifylline
- DRUG Cocaine (IV)
Study Locations (1)
Kentucky
- Psychopharmacology of Addiction Laboratory - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-11-10 |
| Est. Completion | 2028-02-28 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07086794
The ClinicalTrials.gov registry entry for NCT07086794 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 103-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (71% lower). The listed sponsor is William Stoops, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cocaine Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT07086794 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT07086794 about?
NCT07086794 is a clinical study titled "Cocaine and Pentoxifylline (BED IN 47)". This will be a human laboratory study evaluating the influence of pentoxifylline treatment on the effects of cocaine. Supported by and included in the Helping to End Addiction Long-term® (HEAL) Initiative.
What is the current status of trial NCT07086794?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2025-11-10. Estimated completion is 2028-02-28.
What conditions does trial NCT07086794 study?
This clinical trial studies the following conditions: Cocaine Use Disorder.
What interventions are being tested in trial NCT07086794?
The interventions under investigation include: Placebo (DRUG), Pentoxifylline (DRUG), Cocaine (IV) (DRUG).
Who is sponsoring clinical trial NCT07086794?
This trial is sponsored by William Stoops, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07086794 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
RECRUITING · Early Phase 1
-
Imaging CRF X NOP Interactions in CUD
RECRUITING · Early Phase 1
-
[C-11]NPA PET-amphetamine in Cocaine Use Disorders
RECRUITING · Early Phase 1
-
Safety Profile of Psilocybin for Cocaine Use Disorder
RECRUITING · Early Phase 1
-
Targeting Drug Memories With Methylphenidate
ACTIVE NOT RECRUITING · Early Phase 1
-
[11C]NOP-1A and Cocaine Use Disorders
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.